BIOSITE Inc Watch

from S-4 8 pages Sixteenth Supplemental Indenture

from S-4/A 9 pages Eleventh Supplemental Indenture (This “Supplemental Indenture”), Dated as of March 19, 2010, Among New Binax, Inc., New Biosite Incorporated, Alere Newco, Inc., and Alere Newco II, Inc. ( the “New Guarantors”), Subsidiaries of Inverness Medical Innovations, Inc. (Or Its Successor) (The “Issuer”), Inverness Medical Innovations, Inc., a Delaware Corporation, Each of the Guarantors (The “Existing Guarantors”) Under the Indenture Referred to Below, and the Bank of New York Mellon Trust Company, N.A., as Trustee Under the Indenture Referred to Below (The “Trustee”)

from S-4/A 9 pages Tenth Supplemental Indenture (This “Supplemental Indenture”), Dated as of March 19, 2010, Among New Binax, Inc., New Biosite Incorporated, Alere Newco, Inc., and Alere Newco II, Inc. (The “New Guarantors”), Subsidiaries of Inverness Medical Innovations, Inc. (Or Its Successor) (The “Issuer”), Inverness Medical Innovations, Inc., a Delaware Corporation, Each of the Guarantors (The “Existing Guarantors”) Under the Indenture Referred to Below, and the Bank of New York Mellon Trust Company, N.A., as Trustee Under the Indenture Referred to Below (The “Trustee”)

from S-4/A 8 pages Ninth Supplemental Indenture (This “Supplemental Indenture”), Dated as of March 1, 2010, Among Laboratory Specialists of America, Inc., Kroll Laboratory Specialists, Inc., and Scientific Testing Laboratories, Inc. ( the “New Guarantors”), Subsidiaries of Inverness Medical Innovations, Inc. (Or Its Successor) (The “Issuer”), Inverness Medical Innovations, Inc., a Delaware Corporation, Each of the Guarantors (The “Existing Guarantors”) Under the Indenture Referred to Below, and the Bank of New York Mellon Trust Company, N.A., as Trustee Under the Indenture Referred to Below (The “Trustee”)

from S-4/A 8 pages Eighth Supplemental Indenture (This “Supplemental Indenture”), Dated as of March 1, 2010, Among Laboratory Specialists of America, Inc., Kroll Laboratory Specialists, Inc., and Scientific Testing Laboratories, Inc. (The “New Guarantors”), Subsidiaries of Inverness Medical Innovations, Inc. (Or Its Successor) (The “Issuer”), Inverness Medical Innovations, Inc., a Delaware Corporation, Each of the Guarantors (The “Existing Guarantors”) Under the Indenture Referred to Below, and the Bank of New York Mellon Trust Company, N.A., as Trustee Under the Indenture Referred to Below (The “Trustee”)

from 8-A12B 9 pages Eighth Supplemental Indenture (This “Supplemental Indenture”), Dated as of March 19, 2010, Among New Binax, Inc., New Biosite Incorporated, Alere Newco, Inc. and Alere NewCo II, Inc. (Collectively, the “New Guarantors”), Subsidiaries of Inverness Medical Innovations, Inc. (Or Its Successor) (The “Issuer”), Inverness Medical Innovations, Inc., a Delaware Corporation, Each of the Guarantors (The “Existing Guarantors”) Under the Indenture Referred to Below, and U.S. Bank National Association, as Trustee Under the Indenture Referred to Below (The “Trustee”)